Issue 1/2013
Content (30 Articles)
Emerging treatment options for the management of brain metastases in patients with HER2-positive metastatic breast cancer
A. Jo Chien, Hope S. Rugo
The effect of breast reconstruction surgery on body image among women after mastectomy: a meta-analysis
Su-Ying Fang, Bih-Ching Shu, Ying-Ju Chang
Potential implications of adjuvant endocrine therapy for the oral health of postmenopausal women with breast cancer
L. Susan Taichman, Aaron M. Havens, Catherine H. Van Poznak
Cognitive function and breast cancer: promise and potential insights from functional brain imaging
Patricia A. Reuter-Lorenz, Bernadine Cimprich
Detection of disseminated tumor cells in the bone marrow of breast cancer patients using multiplex gene expression measurements identifies new therapeutic targets in patients at high risk for the development of metastatic disease
Chidananda M. Siddappa, Mark A. Watson, Sreeraj G. Pillai, Kathryn Trinkaus, Timothy Fleming, Rebecca Aft
Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer
Karin Milde-Langosch, Thomas Karn, Volkmar Müller, Isabell Witzel, Achim Rody, Markus Schmidt, Ralph M. Wirtz
Prospective dual role of mesenchymal stem cells in breast tumor microenvironment
Christiane Senst, Timo Nazari-Shafti, Stefan Kruger, Kirstin Höner Zu Bentrup, Charles L. Dupin, Abigail E. Chaffin, Sudesh K. Srivastav, Philipp M. Wörner, Asim B. Abdel-Mageed, Eckhard U. Alt, Reza Izadpanah
Molecularly targeted gold nanoparticles enhance the radiation response of breast cancer cells and tumor xenografts to X-radiation
Niladri Chattopadhyay, Zhongli Cai, Yongkyu Luke Kwon, Eli Lechtman, Jean-Philippe Pignol, Raymond M. Reilly
Inhibition of the proliferation of acquired aromatase inhibitor-resistant breast cancer cells by histone deacetylase inhibitor LBH589 (panobinostat)
Makoto Kubo, Noriko Kanaya, Karineh Petrossian, Jingjing Ye, Charles Warden, Zheng Liu, Reiki Nishimura, Tomofumi Osako, Masayuki Okido, Kazuo Shimada, Masato Takahashi, Peiguo Chu, Yate-Ching Yuan, Shiuan Chen
Heparins modulate the IFN-γ-induced production of chemokines in human breast cancer cells
Herbert Fluhr, Tina Seitz, Marek Zygmunt
Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer
Seth Rummel, Erika Varner, Craig D. Shriver, Rachel E. Ellsworth
Lack of expression of the proteins GMPR2 and PPARα are associated with the basal phenotype and patient outcome in breast cancer
B. G. Baker, G. R. Ball, E. A. Rakha, C. C. Nolan, C. Caldas, I. O. Ellis, A. R. Green
The microRNA maturation regulator Drosha is an independent predictor of outcome in breast cancer patients
Sarkawt M. Khoshnaw, Emad A. Rakha, Tarek Abdel-Fatah, Christopher C. Nolan, Zsolt Hodi, R. Douglas Macmillan, Ian O. Ellis, Andrew R. Green
Diffuse reflectance spectroscopy: towards clinical application in breast cancer
Daniel J. Evers, Rami Nachabe, Marie-Jeanne Vranken Peeters, Jos A. van der Hage, Hester S. Oldenburg, Emiel J. Rutgers, Gerald W. Lucassen, Benno H. W. Hendriks, Jelle Wesseling, Theo J. M. Ruers
Plasma estrone sulfate concentrations and genetic variation at the CYP19A1 locus in postmenopausal women with early breast cancer treated with letrozole
G. Lunardi, P. Piccioli, P. Bruzzi, R. Notaro, S. Lastraioli, M. Serra, P. Marroni, C. Bighin, M. Mansutti, F. Puglisi, M. Porpiglia, R. Ponzone, G. Bisagni, O. Garrone, G. Cavazzini, M. Clavarezza, L. Del Mastro
Exercise for health: a randomized, controlled trial evaluating the impact of a pragmatic, translational exercise intervention on the quality of life, function and treatment-related side effects following breast cancer
Sandra C. Hayes, Sheree Rye, Tracey DiSipio, Patsy Yates, John Bashford, Chris Pyke, Christobel Saunders, Diana Battistutta, Elizabeth Eakin
A cost effectiveness study of eribulin versus standard single-agent cytotoxic chemotherapy for women with previously treated metastatic breast cancer
Gilberto Lopes, Stefan Glück, Kiran Avancha, Alberto J. Montero
Patient and tumor characteristics associated with breast cancer recurrence after complete pathological response to neoadjuvant chemotherapy
Na Rae Ju, Donna B. Jeffe, Jason Keune, Rebecca Aft
Different prognostic significance of Ki-67 change between pre- and post-neoadjuvant chemotherapy in various subtypes of breast cancer
Nobuaki Matsubara, Hirofumi Mukai, Satoshi Fujii, Noriaki Wada
SERPINA6, BEX1, AGTR1, SLC26A3, and LAPTM4B are markers of resistance to neoadjuvant chemotherapy in HER2-negative breast cancer
Jorma J. de Ronde, Esther H. Lips, Lennart Mulder, Andrew D. Vincent, Jelle Wesseling, Marja Nieuwland, Ron Kerkhoven, Marie-Jeanne T. F. D. Vrancken Peeters, Gabe S. Sonke, Sjoerd Rodenhuis, Lodewyk F. A. Wessels
Dual association between polyphenol intake and breast cancer risk according to alcohol consumption level: a prospective cohort study
Mathilde Touvier, Nathalie Druesne-Pecollo, Emmanuelle Kesse-Guyot, Valentina A. Andreeva, Léopold Fezeu, Pilar Galan, Serge Hercberg, Paule Latino-Martel
Hypothesized role of pregnancy hormones on HER2+ breast tumor development
Giovanna I. Cruz, María Elena Martínez, Loki Natarajan, Betsy C. Wertheim, Manuela Gago-Dominguez, Melissa Bondy, Adrian Daneri-Navarro, María Mercedes Meza-Montenegro, Luis Enrique Gutierrez-Millan, Abenaa Brewster, Pepper Schedin, Ian K. Komenaka, J. Esteban Castelao, Angel Carracedo, Carmen M. Redondo, Patricia A. Thompson
Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004–2007
Allison W. Kurian, Daphne Y. Lichtensztajn, Theresa H. M. Keegan, Rita W. Leung, Sarah J. Shema, Dawn L. Hershman, Lawrence H. Kushi, Laurel A. Habel, Tatjana Kolevska, Bette J. Caan, Scarlett L. Gomez
Social networks, social support, and burden in relationships, and mortality after breast cancer diagnosis in the Life After Breast Cancer Epidemiology (LACE) Study
Candyce H. Kroenke, Charles Quesenberry, Marilyn L. Kwan, Carol Sweeney, Adrienne Castillo, Bette J. Caan
The association of breast density with breast cancer mortality in African American and white women screened in community practice
Shengfan Zhang, Julie S. Ivy, Kathleen M. Diehl, Bonnie C. Yankaskas
Trends in co-prescribing of antidepressants and tamoxifen among women with breast cancer, 2004–2010
Stacie B. Dusetzina, G. Caleb Alexander, Rachel A. Freedman, Haiden A. Huskamp, Nancy L. Keating
Placental weight and mortality in premenopausal breast cancer by tumor characteristics
Mohammad Hossein Hajiebrahimi, Shahram Bahmanyar, Mats Lambe, Jan Adolfsson, Tommy Fornander, Fredrik Wärnberg, Sven Cnattingius
Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis
Mariaelena Pierobon, Cara L. Frankenfeld
The penetrance of ductal carcinoma in situ among BRCA1 and BRCA2 mutation carriers
Emanuele Mazzola, Su-Chun Cheng, Giovanni Parmigiani
High stearoyl-CoA desaturase 1 expression is associated with shorter survival in breast cancer patients
Ashley M. Holder, Ana M. Gonzalez-Angulo, Huiqin Chen, Argun Akcakanat, Kim-Anh Do, W. Fraser Symmans, Lajos Pusztai, Gabriel N. Hortobagyi, Gordon B. Mills, Funda Meric-Bernstam